This website is intended for healthcare professionals

Tom Allaway


Celebrating non-medical prescribers

As I write my final editorial for the Journal of Prescribing Practice, I reflect on my nearly four-years and the significant developments within the non-medical prescribing sector during this time. It...


The National Institute for Health and Care Excellence (NICE) has recommended a weight loss drug to be made available in specialist NHS services. The drug, semaglutide, has shown promising results in...

New government initiative to reduce cost of HRT for menopausal women

On the 21 February 2023, it was announced that the UK government would start subsidising the price of hormone replacement therapy (HRT), with around 400 000 women in England potentially benefiting...


The UK government has announced a new initiative to make hormone replacement therapy (HRT) more affordable for women experiencing symptoms of menopause. The move is expected to benefit hundreds of...


NICE has recommended a weekly injection for treating growth failure in children. The recommended treatment, known as growth hormone therapy, involves a weekly injection of a hormone called somatropin....

Strike action looms as we enter 2023

Hello and happy New Year from the Journal of Prescribing Practice. As always, when writing a new year editorial, it's important to look to the year ahead and envision what we might encounter. While...


Following the announcement of serious shortage protocols (SSPs) on Thursday, December 15, five new SSPs have been issued..


The batches shown in Table 1 of Targocid 200 mg powder for injection/infusion or oral solution are being recalled immediately by Sanofi UK. This is due to out of specification results for bacterial...

The question of social prescribing

A new review, published in the BMJ Open (Kiely et al, 2022), found that there is no consistent evidence that social prescribing improves social support or physical function, or reduced the use of...


Following the publication of final draught National Institute for Health and Care Excellence (NICE) guidance on 23 September 2022, approximately 1500 people aged 12 years and older with melanoma are...

Drug updates: August

Following a deal with the manufacturer of Dexcom One, patients with type 1 diabetes in England are now eligible for continuous glucose monitors (CGMs). Until recently, the only CGMs widely available...


The National Institute of Health and Care Excellence (NICE) has published final draft guidance recommending icosapent ethyl to reduce the risk of cardiovascular events such as heart attacks and...

Prescribing updates: July

The UK government has published a new drug safety update on the use of metformin and its effects on a patient's vitamin B12 levels..

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP